摘要:
Disclosed is the therapeutic use of CpG oligodeoxynucleotides for skin diseases. The CpG oligodeoxynucleotides (CpG ODNs) of the present invention show excellent immunoactive effects against skin diseases in both cases of CpG ODNs with a phosphorothioate backbone and CpG ODNs with a phosphodiester backbone.
摘要:
Disclosed is the therapeutic use of CpG oligodeoxynucleotides for skin diseases. The CpG oligodeoxynucleotides (CpG ODNs) of the present invention show excellent immunoactive effects against skin diseases in both cases of CpG ODNs with a phosphorothioate backbone and CpG ODNs with a phosphodiester backbone.
摘要:
Disclosed are oligonucleotides for manipulating an immune reaction. The oligonucleotides of the present invention may be useful to stimulate the immune function, to treat the immune-related diseases and the atopic dermatitis, or to protect the normal immune cells.
摘要:
Disclosed are oligonucleotides for manipulating an immune reaction. The oligonucleotides of the present invention may be useful to stimulate the immune function, to treat the immune-related diseases and the atopic dermatitis, or to protect the normal immune cells.
摘要:
Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.
摘要:
Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.
摘要:
The present invention relates to a new use of capsiate or dihydrocapsiate, more particularly to a composition for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease or for suppressing immunity comprising capsiate, dihydrocapsiate or a pharmaceutically acceptable salt thereof as an effective ingredient. The composition and immunosuppressant of the present invention may be used for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease, and for suppressing immunity.
摘要:
A fuel cell stack including membrane-electrode assemblies and separators formed between each of the membrane-electrode assemblies is disclosed. The membrane-electrode assemblies may each include an electrolyte membrane, an anode formed on a first surface of the electrolyte membrane, and a cathode formed on a second surface of the electrolyte membrane. Each of the separators may include an anode separator facing the anode and a cathode separator facing the cathode. Each of the separators may include at least two manifolds, a channel separated from the manifolds and facing either the anode or the cathode, and a connection channel fluidly connecting the manifold and the channel. The separator may also include a buffer protrusion system in the connection channel configured to disperse the flow of the fuel or the oxidant.
摘要:
An electricity generator includes a membrane electrode assembly; a separator coupled to the membrane electrode assembly and including a first region and a second region; and a thermal conductor on one of the first region and the second region.
摘要:
A semiconductor device includes a triangle prism pillar having a first, a second, and a third sidewall surface, a bit line contacted with the first sidewall surface of the pillar, and a word line adjacent to the second sidewall surface of the pillar over the bit line.